News and Announcements
Shivom Covered on David Pakman Show, Finance News Network, and ICO review
- Published April 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom featured on the Finance News Network, David Pakman Show, and ICO Review
- Shivom generates a traction through its futuristic interlocking of blockchain technology and genomic data.
Shivom is creating a lot of buzz with its unique and futuristic interlocking of blockchain technology and genomic data. Recently, Shivom’s CEO Axel Schumacher and CIO Henry Ines have been featured on the Finance News Network, David Pakman Show, and ICO Review.
The videos offer insights on the project, Shivom’s ICO offering, and include interviews with Co-Founders of Shivom and their vision, respectively.
You can view the videos at:
ICO Review – https://youtu.be/u62-J7QWpMA
David Pakman show featuring Henry Ines – https://www.youtube.com/watch?
Finance News Network featuring Dr. Axel Schumacher and Henry Ines –https://www.youtube.com/watch?
These videos highlight Shivom’s prospects and its purpose of decentralising DNA and genomic data while ensuring full control and privacy to the DNA donors and genomic data providers.
Watch the Co-founding team talk to experts and explain the idea behind Shivom’s creation as they also provide a perspective on the future of precision medicine, DNA-based medical research, blockchain solutions and the importance of encrypting sensitive information DNA. In these videos, they also address concerns surrounding Shivom’s proposed use of the blockchain technology and genomic information.
We would also like to inform you that we are nearing the crowd sale event of our OmiX token which is only a few days from now.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
